Endocrine treatment mechanisms in triple-positive breast cancer: from targeted therapies to advances in precision medicine

Endocrine treatment mechanisms in triple-positive breast cancer: from targeted therapies to advances in precision medicine

Triple-positive breast cancer (TPBC), defined by the co-expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), poses unique therapeutic challenges due to complex signaling interactions and resulting treatment resistance. This review sum...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiu Yang, Daxin Yang, Xue Qi, Xiujuan Luo, Guangmei Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
triple-positive breast cancer
molecular mechanisms
endocrine therapy resistance
precision medicine
gene editing (CRISPR/Cas9)
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1467033/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items